UKPMC Funders Group Author Manuscript Mol Psychiatry. Author manuscript; available in PMC 2009 January 22.
|
|
- Kristopher Wilfrid Merritt
- 5 years ago
- Views:
Transcription
1 UKPMC Funders Group Author Manuscript Published in final edited form as: Mol Psychiatry July ; 13(7): doi: /mp D-Amino acid oxidase (DAO) activity and expression are increased in schizophrenia PWJ Burnet, SL Eastwood, GC Bristow, BR Godlewska, P Sikka, M Walker, and PJ Harrison Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX3 7JX, United Kingdom. Keywords Glutamate; bipolar disorder; DAAO; NMDA receptor; D-serine; polymorphism D-amino acid oxidase (DAO, DAAO) metabolises the NMDA receptor (NMDAR) modulator D-serine. 1 Enhanced DAO activity is thus a potential cause of reduced D-serine and thence impaired NMDAR functioning in schizophrenia, 2 and an explanation for the genetic contribution that DAO may make to the disorder. 3,4 Here we report that DAO activity, and expression, are increased in the cerebellum in schizophrenia, but not in bipolar disorder, and are not related to SNPs in DAO or its putative activator gene G72/G30. 3 We measured DAO enzyme activity, and DAO mrna by qrt-pcr, using established methods, in cerebellar tissue from subjects with schizophrenia, bipolar disorder, and controls, from the Stanley Microarray Collection (Supplementary Table 1). We genotyped subjects for two schizophrenia-associated tag SNPs in DAO and G72/G30. We used cerebellar tissue from rats administered haloperidol or clozapine for 14 days to investigate antipsychotic effects on DAO activity. For demographic and methodological details, see Supplementary Materials. As shown in Fig. 1A, DAO activity differed between groups (F 2,100 =4.79, p=0.010), being increased in schizophrenia compared to controls (+37%, p=0.027) and compared to bipolar disorder (+57%, p=0.004). The latter groups did not differ (p=0.45). DAO activity was not correlated with post mortem interval, brain ph, or antipsychotic exposure (Supplementary Fig. 1) or age (R=0.03, p=0.79). DAO activity was unrelated to alcohol or substance misuse history (using a five-point scale), smoking, sex, or suicide. DAO activity increased with duration of schizophrenia (R=0.34, p=0.05, n=35). Within the bipolar disorder group, DAO activity did not vary according to a history of psychotic symptoms. DAO activity correlated with DAO mrna (R=0.43, p=0.0001, n=97). DAO affinity showed no group differences (Fig. 1B). DAO activity in rat cerebellum was unaffected by antipsychotics (Supplementary Table 2). Normalised DAO mrna differed between groups (F 2,88 =3.84, p=0.025), being increased compared to controls in schizophrenia (p=0.01) and bipolar disorder (p=0.04; Fig. 1C). DAO mrna was not related to antipsychotic exposure, post mortem interval, brain ph, or RIN, but was affected by death-to-refrigeration interval (Supplementary Fig. 1). Neither DAO activity nor DAO mrna were influenced by the DAO or G72/G30 SNPs (Supplementary Table 3), apart from a trend for higher DAO activity in allele 2 carriers of Correspondence: Dr Harrison. paul.harrison@psych.ox.ac.uk Tel: Fax
2 Burnet et al. Page 2 G72/G30 rs (p=0.08 vs 1/1 homozygotes). There were no genotype-by-diagnosis interactions. Our data show an elevation of DAO activity in schizophrenia accompanied by increased gene expression. The activity increase confirms the results of a pilot study, 5 and the elevated DAO mrna replicates findings in a separate cohort. 6 There were no correlations of DAO activity or expression with medication exposure, and no effect of haloperidol or clozapine on DAO activity in rat brain. Other confounders (e.g. smoking) did not have a demonstrable influence either. Hence, within the constraints of a post mortem study, our findings appear related to the diagnosis of schizophrenia. We focused on the cerebellum because DAO is abundant and active therein; it will be important to ascertain whether DAO activity is affected elsewhere in schizophrenia, but problematic since forebrain DAO activity is extremely low, despite robust expression. Parenthetically, this discrepancy is complemented by a difference in the cellular localization of DAO: it is glial in the cerebellum, but mainly neuronal in the cerebral cortex. 6 Elevated DAO activity will presumably enhance metabolism of D-serine and, other things being equal, contribute to a reduced synaptic availability of D-serine, potentially impairing NMDAR function. 1 As such, our findings support the hypothesized involvement of DAO, and thence D-serine, in the NMDAR hypofunction of schizophrenia and its potential therapeutic amelioration. 2,7,8 Clearly any such conclusions are tentative, since many other factors likely also influence D-serine availability, e.g. its synthesis by serine racemase, 6,9 and its release and reuptake. 10 Alterations in these processes could counteract or exacerbate enhanced DAO activity. Moreover, since DAO also metabolises other D-amino acids, 1 D-serine is not the only substrate that might be affected by an increase in DAO activity. For example, D-alanine is present in the cerebellum, is an NMDAR modulator, and may be therapeutically beneficial in schizophrenia. 7 Overall, whilst a primary effect on D-serine, and thence NMDARs, is an attractive interpretation of the DAO increase in schizophrenia, further studies are needed to confirm the biochemical consequences, as well as the causes, of the elevation. (See Supplementary Materials for further discussion). As the DAO and G72/G30 SNPs did not influence DAO activity or expression, our data provide no evidence that they are functional (nor indexing SNPs that are), nor have we identified a mechanism whereby variation in these genes might confer schizophrenia susceptibility. There may be other SNPs that are relevant in this respect; alternatively, the DAO SNPs might operate at other places and times, whilst G72/G30 SNPs could act via a DAO-independent pathway. In summary, DAO activity and expression are increased in schizophrenia, but not related to DAO or G72/G30 genotype. Any pathophysiological consequences of increased DAO activity seem most likely to impact on D-serine metabolism and thence NMDAR function, but this remains to be established. Supplementary Material References Refer to Web version on PubMed Central for supplementary material. 1. Mothet JP, Parent AT, Wolosker H, Brady RO, Linden DJ, Ferris CD, et al. Proc Natl Acad Sci USA 2000;97: [PubMed: ] 2. Tsai GC, Coyle JT. Annu Rev Pharmacol Toxicol 2002;42: [PubMed: ] 3. Chumakov I, Blumenfeld M, Guerrasimenko O, Cavarec L, Palicio M, Abderrahim H, et al. Proc Natl Acad Sci USA 2002;99: [PubMed: ] 4. Boks MPM, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS. Eur Neuropsychopharmacol 2007;17: [PubMed: ]
3 Burnet et al. Page 3 5. Kapoor R, Lim KS, Cheng A, Garrick T, Kapoor V. Brain Res 2006;1106: [PubMed: ] 6. Verrall L, Walker M, Rawlings N, Benzel I, Kew JNC, Harrison PJ, Burnet PJW. Eur J Neurosci 2007;26: [PubMed: ] 7. Javitt D. Biol Psychiatry 2008;63:6 8. [PubMed: ] 8. Adage T, Trillat A-C, Quattropani A, Perrin D, Cavarec L, Shaw J, et al. Eur Neuropsychopharmacol 2008;18: [PubMed: ] 9. Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, Agam G. Schizophr Res 2007;90: [PubMed: ] 10. Burnet PJW, Hutchinson L, von Hesling M, Gilbert E-J, Harrison PJ. Schizophr Res. in press
4 Burnet et al. Page 4 Figure 1. Cerebellar DAO activity and expression in 35 control subjects (CON, white bars), 35 with schizophrenia (SCZ, black bars), and 34 with bipolar disorder (BPD, shaded bars). A) DAO activity (Vmax, nmol D-proline/min/mg protein) is higher in subjects with schizophrenia compared to controls and to subjects with bipolar disorder. Bipolar disorder subjects have lower DAO activity than those with schizophrenia. B) DAO affinity (Km, nm) is not different between groups. C) DAO mrna, measured by Taqman qrt-pcr and normalised to the geometric mean of four housekeeping genes (β2m, GAPDH, GUSB, TFRC; see Supplementary Materials), is increased in subjects with schizophrenia and in bipolar disorder. 5 subjects (1 CON, 1 SCZ, 3 BPD) were excluded due to amplification failure. The death-to-
5 Burnet et al. Page 5 refrigeration interval was included as a covariate in this analysis as it correlated negatively with DAO mrna (Supplementary Figure 1D). Repeating the ANOVA without this covariate retained the overall diagnostic effect (F 2,95 =3.422, p=0.037) and the increase in schizophrenia (p=0.01) but rendered the bipolar disorder increase non-significant (p=0.22).
Simple Solution for Challenging Questions of CNS Disorders; One Size Fit It All? G. Emil Tsai, MD, PhD UCLA School of Medicine
Simple Solution for Challenging Questions of CNS Disorders; One Size Fit It All? G. Emil Tsai, MD, PhD UCLA School of Medicine Disclosure Consultant: Amgen, Genentech,, Chugai SyneuRx International ( 心悅生醫
More informationLack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims
Kobe J. Med. Sci., Vol. 53, No. 4, pp. 151-155, 2007 Lack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims KAORU SAKURAI 1, NAOKI NISHIGUCHI 2, OSAMU SHIRAKAWA 2,
More informationUniversity of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke
University of Groningen Metabolic risk in people with psychotic disorders Bruins, Jojanneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationNeuroscience and Biobehavioral Reviews
Neuroscience and Biobehavioral Reviews 34 (2010) 351 372 Contents lists available at ScienceDirect Neuroscience and Biobehavioral Reviews journal homepage: www.elsevier.com/locate/neubiorev Review The
More informationSensory Gating Measures. Auditory P50 Response Prepulse Inhibition of Startle (PPI) Bruce Turetsky, M.D. IOM Workshop June 22, 2010
Sensory Gating Measures Auditory P50 Response Prepulse Inhibition of Startle (PPI) Bruce Turetsky, M.D. IOM Workshop June 22, 2010 Heuristically, sensory gating denotes the ability to filter out irrelevant
More informationCORTICAL DEFICITS IN SCHIZOPHRENIA From Genes to Function
CORTICAL DEFICITS IN SCHIZOPHRENIA From Genes to Function CORTICAL DEFICITS IN SCHIZOPHRENIA From Genes to Function Edited by Patricio O Donnell University of Maryland, Baltimore, MD, USA Patricio O Donnell
More informationD-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine
SYNAPTIC NEUROSCIENCE ORIGINAL RESEARCH ARTICLE published: 02 May 2014 doi: 10.3389/fnsyn.2014.00011 D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine Jill
More informationInhibition of D-Amino Acid Oxidase Activity by Antipsychotic Drugs Evaluated by a Fluorometric Assay Using D-Kynurenine as Substrate
YAKUGAKU ZASSHI 131(7) 1111 1116 (2011) 2011 The Pharmaceutical Society of Japan 1111 Note Inhibition of D-Amino Acid Oxidase Activity by Antipsychotic Drugs Evaluated by a Fluorometric Assay Using D-Kynurenine
More informationGenetic Vulnerability to Psychosis and Cortical Function: Epistatic Effects between DAAO and G72
Genetic Vulnerability to Psychosis and Cortical Function: Epistatic Effects between DAAO and G72 Mechelli Andrea 1, Prata Diana 1,2, Papagni Sergio Alessandro 1,3, Tognin Stefania 1, Kambeitz Joseph 1,
More informationSUPPLEMENTARY INFORMATION
Supplementary Figure 1. Behavioural effects of ketamine in non-stressed and stressed mice. Naive C57BL/6 adult male mice (n=10/group) were given a single dose of saline vehicle or ketamine (3.0 mg/kg,
More informationSupplemental Table I
Supplemental Table I Cortex Hippocampus Age (weeks) Genotype STE 61 pste 61 STE 61 pste 61 8 100.0 ± 4.4 96.2 ± 6.0 99.8 ± 8.7 167.5 ± 7.8* 100.0 ± 7.0 90.5 ± 13.8 100.0 ± 12.8 260.4 ± 33.9** 12 100.0
More informationESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal
ESSENTIAL PSYCHOPHARMACOLOGY, 2011 Neurobiology of Schizophrenia Carl Salzman MD Montreal EVOLVING CONCEPTS OF SCHIZOPHRENIA Psychotic illness with delusions, hallucinations, thought disorder and deterioration;
More informationThalamocortical Synchronization and Cognition: Implications for Schizophrenia?
Published in final edited form as: Neuron 77(6), 997 999. doi: http://dx.doi.org/10.1016/j.neuron.2013.02.033 Thalamocortical Synchronization and Cognition: Implications for Schizophrenia? Peter J. Uhlhaas
More informationUse of Genetics to Inform Drug Development of a Novel Treatment for Schizophrenia
Use of Genetics to Inform Drug Development of a Novel Treatment for Schizophrenia March 21, 2012 Institute of Medicine: New Paradigms in Drug Discovery Workshop Laura K. Nisenbaum, PhD Translational Medicine,
More information2) Cases and controls were genotyped on different platforms. The comparability of the platforms should be discussed.
Reviewers' Comments: Reviewer #1 (Remarks to the Author) The manuscript titled 'Association of variations in HLA-class II and other loci with susceptibility to lung adenocarcinoma with EGFR mutation' evaluated
More informationThe NMDA receptor is activated by the neurotransmitter
Serine racemase: Activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration Paul M. Kim*, Hiroyuki Aizawa, Peter S. Kim*, Alex S. Huang, Sasrutha
More informationReduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia
Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia C. Christoph Schultz, Igor Nenadic, Kathrin Koch, Gerd Wagner, Martin Roebel,
More informationThe Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors
The Open Medicinal Chemistry Journal, 2010, 4, 3-9 3 Open Access The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors Sean M. Smith*, Jason M. Uslaner and Peter H. Hutson Merck & Co., Inc.,
More informationAn Introduction to Principles and Practice July 8, Presented by
An Introduction to Principles and Practice July 8, 2011 Presented by Biomarkers in Psychiatry Jay Lombard, DO Chief Scientific Officer and Medical Director Genomind 2 Our mission is to advance the care
More informationSupplementary Information
Supplementary Information D-Serine regulates cerebellar LTD and motor coordination through the 2 glutamate receptor Wataru Kakegawa, Yurika Miyoshi, Kenji Hamase, Shinji Matsuda, Keiko Matsuda, Kazuhisa
More informationand neurodegeneration
MINIREVIEW D-Amino acids in the brain: D-serine in neurotransmission and neurodegeneration Herman Wolosker, Elena Dumin, Livia Balan and Veronika N. Foltyn Department of Biochemistry, B. Rappaport Faculty
More informationNIH Public Access Author Manuscript Nat Neurosci. Author manuscript; available in PMC 2006 September 5.
NIH Public Access Author Manuscript Published in final edited form as: Nat Neurosci. 2006 August ; 9(8): 1004 1006. Maternal presence serves as a switch between learning fear and attraction in infancy
More informationSupplementary information
Supplementary information Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study Juan Wen, Ci
More informationCellular levels of D-amino acid oxidase are modulated through plg72 interaction
Cellular levels of D-amino acid oxidase are modulated through plg72 interaction Cappelletti P., Pollegioni L. and Sacchi S. Dipartimento di Biotecnologie e Scienze della Vita, Università degli studi dell
More informationEvidence that D-Serine is a Co-agonist to NMDA Receptors at the Crayfish Neuromuscular Junction.
Pioneering Neuroscience, 2013, 13, 33-38. Evidence that D-Serine is a Co-agonist to NMDA Receptors at the Crayfish Neuromuscular Junction. DANIELLE HUEBNER, XIAOXUAN YANG, and MEGAN HERVEY Department of
More informationMental Health DNA Insight WHITE PAPER
Mental Health DNA Insight WHITE PAPER JULY 2016 Mental Health DNA Insight / White Paper Mental Health DNA Insight Pathway Genomics Mental Health DNA Insight test is aimed to help psychiatrists, neurologists,
More informationPSY/NEU338: Animal learning and decision making: Psychological, computational and neural perspectives
Too much dopamine can be bad for you: 1I. Latent inhibition and schizophrenia PSY/NEU338: Animal learning and decision making: Psychological, computational and neural perspectives thanks to Ina Weiner
More informationTitle:The effect of CD14 and TLR4 gene polimorphisms on asthma phenotypes in adult Turkish asthma patients: a genetic study
Author's response to reviews Title:The effect of CD14 and TLR4 gene polimorphisms on asthma phenotypes in adult Turkish asthma patients: a genetic study Authors: Fusun Sahin (fusunsahin19700@hotmail.com)
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hartman M, Loy EY, Ku CS, Chia KS. Molecular
More informationRisperidone Case 1: Drug-Drug Interactions
Risperidone Case 1: Drug-Drug Interactions 1-14-16 de Leon & Bork (a resident) J Clin Psychiatry 1997;58:450-1 http://www.ncbi.nlm.nih.gov/pubmed/9375597 Jose de Leon, MD Educational Objectives At the
More informationGenes, Aging and Skin. Helen Knaggs Vice President, Nu Skin Global R&D
Genes, Aging and Skin Helen Knaggs Vice President, Nu Skin Global R&D Presentation Overview Skin aging Genes and genomics How do genes influence skin appearance? Can the use of Genomic Technology enable
More informationPharmacogenetics in: Primary Care. Bradley T. Wajda D.O.
Pharmacogenetics in: Primary Care Bradley T. Wajda D.O. Pharmacogenomics Defined Pharmacogenomics uses information about a person s genetic makeup, or genome, to choose the drugs and drug doses that are
More informationDoes prenatal alcohol exposure affect neurodevelopment? Attempts to give causal answers
Does prenatal alcohol exposure affect neurodevelopment? Attempts to give causal answers Luisa Zuccolo l.zuccolo@bristol.ac.uk MRC IEU, School of Social and Community Medicine Background Prenatal alcohol
More informationSupplementary Figure 1. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations.
Supplementary Figure. Principal components analysis of European ancestry in the African American, Native Hawaiian and Latino populations. a Eigenvector 2.5..5.5. African Americans European Americans e
More informationAssociation analysis of the GRM8 gene with schizophrenia in the Uygur Chinese population
Hereditas 151: 140 144 (2014) Association analysis of the GRM8 gene with schizophrenia in the Uygur Chinese population LILI ZHANG1, XIANJIANG ZHONG1, ZHIGUO AN1, SHUXIAN HAN1, XIAO LUO1, YONGYONG SHI2
More informationThe Neurobiology of Psychiatric Disorders
The Neurobiology of Psychiatric Disorders Vikaas S. Sohal, MD PhD Department of Psychiatry Center for Integrative Neuroscience Sloan Swartz Center for Theoretical Neurobiology Overview 1. Classification
More informationOutline. Outline. Background Literature and Slides 10/23/2013. The Schizophrenia Research Forum online: Molecules, Neural Networks and Behavior
Background Literature and Slides Molecules, Neural Networks and Behavior Roberto Fernández Galán, PhD Assistant Professor of Neurosciences Mt. Sinai Health Care Foundation Scholar Alfred P. Sloan Research
More informationCONTROVERSIES AND NEW DIRECTIONS
BIPOLAR Introduction DISORDER IN CHILDHOOD AND EARLY ADOLESCENCE Introduction MELISSA P. D ELBELLO, DAVID AXELSON, and BARBARA GELLER CONTROVERSIES AND NEW DIRECTIONS Although the existence and diagnostic
More informationGenetic Analysis of Protein Phosphatase 1 Regulatory Subunit 1B (PPP1R1B) Gene among Autistic Patients
Australian Journal of Basic and Applied Sciences, 5(6): 1-5, 2011 ISSN 1991-8178 Genetic Analysis of Protein Phosphatase 1 Regulatory Subunit 1B (PPP1R1B) Gene among Autistic Patients Nabil S. Awad and
More informationAdd-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor
Research Original Investigation Add-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor Hsien-Yuan Lane, MD, PhD; Ching-Hua
More informationThe relevance of D2-AKT1 signalling for the pathophysiology of cannabis-induced psychosis.
The relevance of D2-AKT1 signalling for the pathophysiology of cannabis-induced psychosis Edinburgh, 14 April 2016 Dr Marco Colizzi marco.v.colizzi@kcl.ac.uk Developmental cascade towards psychosis Family
More informationGenetic association of BDNF val66met and GSK-3b-50T/C polymorphisms with tardive dyskinesia
Psychiatry and Clinical Neurosciences 2009; 63: 433 439 doi:10.1111/j.1440-1819.2009.01976.x Regular Article Genetic association of BDNF val66met and GSK-3b-50T/C polymorphisms with tardive dyskinesia
More informationSchizophrenia FAHAD ALOSAIMI
Schizophrenia FAHAD ALOSAIMI MBBS, SSC - PSYCH C ONSULTATION LIAISON PSYCHIATRIST K ING SAUD UNIVERSITY Schizophrenia - It is not a single disease but a group of disorders with heterogeneous etiologies.
More informationFrom Patients to Therapies. How could the BADIPS challenge progress towards improved in vitro models and novel patient therapies?
From Patients to Therapies How could the BADIPS challenge progress towards improved in vitro models and novel patient therapies? 1 Aim of the BADIPS project 2 Overall objective BADIPS project The development
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10643 Supplementary Table 1. Identification of hecw-1 coding polymorphisms at amino acid positions 322 and 325 in 162 strains of C. elegans. WWW.NATURE.COM/NATURE 1 Supplementary Figure
More informationOut with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications
Program Outline Out with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Rajiv Tandon, MD Professor of Psychiatry University of Florida College of Medicine
More informationANTIPSYCHOTIC POLYPHARMACY
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANTIPSYCHOTIC POLYPHARMACY RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UWMC GENERAL DISCLOSURES The University
More informationSupplementary Online Content
Supplementary Online Content Hulshoff Pol HE, van Baal GCM, Schnack HG, Brans RGH, van der Schot AC, Brouwer RM, van Haren NEM, Lepage C, Collins DL, Evans AC, Boomsma DI, Nolen W, Kahn RS. Overlapping
More informationGlutamate Overview. How can one neurotransmitter have so many diverse functions?
tamate Overview How can one neurotransmitter have so many diverse functions? Darryle Schoepp, Ph.D. Senior Vice President and Franchise Head, Neuroscience Control of Excitability via Amino Acid Neurotransmitters
More informationExperimental Medicine and Psychiatry Drug Development. John H. Krystal, M.D. Yale University
Experimental Medicine and Psychiatry Drug Development John H. Krystal, M.D. Yale University Four problems We don t know the disorders sufficiently The biology is complex and heterogeneous We have animal
More informationBIO333 Comparative Physiology and Pharmacology of Sleep. Genetics of Sleep December 3, Raphaelle Winsky-Sommerer, PhD, PD
BIO333 Comparative Physiology and Pharmacology of Sleep Genetics of Sleep December 3, 2011 Raphaelle Winsky-Sommerer, PhD, PD r.winsky-sommerer@surrey.ac.uk Genetics of Sleep Quantitative traits are determined
More informationAssociation between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk B.B. Sun, J.Z. Wu, Y.G. Li and L.J. Ma Department of Respiratory Medicine, People s Hospital Affiliated to
More informationPolymorphic Variations in 5 HT2A, 5 HTT and DISC 1 in first episode schizophrenia patients
PolymorphicVariationsin5 HT2A,5 HTTandDISC1infirst episodeschizophreniapatients L.MedinaGonzález,DepartmentofClinicalChemistry,RamónyCajalHospital,Madrid. PhD.MJArranz,SectionofClinicalNeuropharmacologyattheInstituteofPsychiatry,
More informationUniversity of Wollongong. Research Online
University of Wollongong Research Online University of Wollongong Thesis Collection 1954-2016 University of Wollongong Thesis Collections 2007 Neurotransmitter receptor binding in the posterior cingulate
More informationLack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population
Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population J. Zhu 1 *, F. He 2 *, D.D. Zhang 2 *, J.Y. Yang 2, J. Cheng 1, R. Wu 1, B. Gong 2, X.Q. Liu
More informationMethod. NeuRA Negative symptoms April 2016
Introduction The negative symptoms of schizophrenia refer to an absence of normal functions. This may include (but is not limited to); blunted affect, which is a scarcity of facial expressions of emotion,
More informationDepartment of Psychiatry, Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
Association study of suppressor with morphogenetic effect on genitalia protein 6 (SMG6) polymorphisms and schizophrenia symptoms in the Han Chinese population Hongyan Yu 1,, Yongfeng Yang 1,2,3,, Wenqiang
More informationAngus W. MacDonald, III with Dori Henderson University of Minnesota Associate Professor of Psychology & Psychiatry
Angus W. MacDonald, III with Dori Henderson University of Minnesota Associate Professor of Psychology & Psychiatry Working Memory and PFC Working memory refers to a collection of storage and executive
More informationEffects of Ketamine on Healthy Participants and Individuals Suffering from Schizophrenia. John Smith. Physiological Foundations of Psychology 71733
Effects of Ketamine on Healthy Participants and Individuals Suffering from Schizophrenia John Smith Physiological Foundations of Psychology 71733 Long Beach City College, Spring 2002 Abstract The purpose
More informationHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Human Molecular Genetics, 2006, Vol. 15, No. 21 3132 3145 doi:10.1093/hmg/ddl253 Advance Access published on September 19, 2006 Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationSupplementary Figure 1. Nature Genetics: doi: /ng.3736
Supplementary Figure 1 Genetic correlations of five personality traits between 23andMe discovery and GPC samples. (a) The values in the colored squares are genetic correlations (r g ); (b) P values of
More informationGeneral Discussion 4
General Discussion 4 General Discussion 115 Introduction Psychiatry is considered to be one of the first medical disciplines that will implement pharmacogenetic testing in daily clinical practice. The
More informationResults. Introduction
(2009) 10, S95 S120 & 2009 Macmillan Publishers Limited All rights reserved 1466-4879/09 $32.00 www.nature.com/gene ORIGINAL ARTICLE Analysis of 55 autoimmune disease and type II diabetes loci: further
More informationAntipsychotics: The Essentials. Module 5: A Primer on Selected Antipsychotics
Antipsychotics: The Essentials Module 5: A Primer on Selected Antipsychotics Slide 1 Recently approved antipsychotics Iloperidone (Fanapt) - 2009 Asenapine (Saphris, Sycrest) - 2009 Lurasidone (Latuda)
More informationTitle: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study
Author's response to reviews Title: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study Authors: Bernd Frank (b.frank@dkfz.de) Heiko Müller (h.mueller@dkfz.de) Melanie
More informationIntroduction to the Genetics of Complex Disease
Introduction to the Genetics of Complex Disease Jeremiah M. Scharf, MD, PhD Departments of Neurology, Psychiatry and Center for Human Genetic Research Massachusetts General Hospital Breakthroughs in Genome
More informationAssociation of a Nonsynonymous Variant of DAOA with Visuospatial Ability in a Bipolar Family Sample
Association of a Nonsynonymous Variant of DAOA with Visuospatial Ability in a Bipolar Family Sample The MIT Faculty has made this article openly available. Please share how this access benefits you. Your
More informationRegence. Medical Policy Manual. Date of Origin: May Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment
Regence Medical Policy Manual Topic: Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment Date of Origin: May 2013 Section: Genetic Testing Last Reviewed Date: June 2013
More informationPharmacogenomics. Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia
For reprint orders, please contact: reprints@futuremedicine.com Pharmacogenomics Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia Aim: To evaluate the effect of functional
More informationPsychopharmacology of AXS-05: Potential Clinical Implications
AXS-05 R&D Day April 24, 208 Psychopharmacology of AXS-05: Potential Clinical Implications Dr. Stephen M. Stahl Adjunct Professor of Psychiatry, University of California San Diego Honorary Visiting Senior
More informationSupplementary Figure 1. Quantile-quantile (Q-Q) plots. (Panel A) Q-Q plot graphical
Supplementary Figure 1. Quantile-quantile (Q-Q) plots. (Panel A) Q-Q plot graphical representation using all SNPs (n= 13,515,798) including the region on chromosome 1 including SORT1 which was previously
More informationAssociation Study of RGS2 Gene Polymorphisms with Panic Disorder in Japanese
Kobe J. Med. Sci., Vol. 55, No. 5, pp. E116-E121, 2009 Association Study of RGS2 Gene Polymorphisms with Panic Disorder in Japanese KENTARO MOURI 1, AKITOYO HISHIMOTO 1*, MASAAKI FUKUTAKE 1, NAOKI NISHIGUCHI
More informationPathophysiology of Patients with Schizophrenia: Genetic and Environmental Factors
Special Reviews Juntendo Medical Journal 2017. 63(1), 8-16 Pathophysiology of Patients with Schizophrenia: Genetic and Environmental Factors TOHRU OHNUMA *,HEII ARAI * *Juntendo University Schizophrenia
More informationPCN FRONTIER REVIEW. Glutamate hypothesis in schizophrenia. Psychiatry and PCNClinical Neurosciences
PCN FRONTIER REVIEW PCN Yota Uno, MD, PhD 1,2,3 * and Joseph T. Coyle, MD 1,2 Schizophrenia is a chronic and severe psychiatric disorder that has profound impact on an individual s life and on society.
More informationSupplementary Information
Supplementary Information Modelling the Yeast Interactome Vuk Janjić, Roded Sharan 2 and Nataša Pržulj, Department of Computing, Imperial College London, London, United Kingdom 2 Blavatnik School of Computer
More informationTHE ROLE OF THE GLUTAMATERGIC SYSTEM IN PSYCHIATRIC BEHAVIORAL ENDOPHENOTYPES IN MICE: IMPLICATIONS FOR SCHIZOPHRENIA.
THE ROLE OF THE GLUTAMATERGIC SYSTEM IN PSYCHIATRIC BEHAVIORAL ENDOPHENOTYPES IN MICE: IMPLICATIONS FOR SCHIZOPHRENIA By Viviane Labrie A thesis submitted in conformity with the requirements for the degree
More informationNeuroImage 56 (2011) Contents lists available at ScienceDirect. NeuroImage. journal homepage:
NeuroImage 56 (2011) 2283 2291 Contents lists available at ScienceDirect NeuroImage journal homepage: www.elsevier.com/locate/ynimg Differential effects of DAAO on regional activation and functional connectivity
More informationCHAPTER 3. Schizophrenia and Antipsychotic Treatment
CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia
More informationAssociation of plasma uric acid with ischemic heart disease and blood pressure:
Association of plasma uric acid with ischemic heart disease and blood pressure: Mendelian randomization analysis of two large cohorts. Tom M Palmer, Børge G Nordestgaard, DSc; Marianne Benn, Anne Tybjærg-Hansen,
More informationAutism shares features with cerebellar syndromes
NEWS Autism shares features with cerebellar syndromes BY KELLY RAE CHI 3 DECEMBER 2009 1 / 7 2 / 7 Misshapen structures: MRI scans show that, compared with controls (A), the cerebellum of a child with
More informationDan Koller, Ph.D. Medical and Molecular Genetics
Design of Genetic Studies Dan Koller, Ph.D. Research Assistant Professor Medical and Molecular Genetics Genetics and Medicine Over the past decade, advances from genetics have permeated medicine Identification
More informationNature Genetics: doi: /ng Supplementary Figure 1
Supplementary Figure 1 Illustrative example of ptdt using height The expected value of a child s polygenic risk score (PRS) for a trait is the average of maternal and paternal PRS values. For example,
More informationDoing more with genetics: Gene-environment interactions
2016 Alzheimer Disease Centers Clinical Core Leaders Meeting Doing more with genetics: Gene-environment interactions Haydeh Payami, PhD On behalf of NeuroGenetics Research Consortium (NGRC) From: Joseph
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/38506 holds various files of this Leiden University dissertation. Author: Nies, Jessica Annemarie Bernadette van Title: Early identification of rheumatoid
More informationSupplementary Figure 1 Forest plots of genetic variants in GDM with all included studies. (A) IGF2BP2
Supplementary Figure 1 Forest plots of genetic variants in GDM with all included studies. (A) IGF2BP2 rs4402960, (B) MTNR1B rs10830963, (C) TCF7L2 rs7903146, (D) IRS1 rs1801278, (E) PPARG rs1801282, (F)
More informationAPPLICATIONS OF ASL IN NEUROSCIENCE
APPLICATIONS OF ASL IN NEUROSCIENCE Luis Hernandez-Garcia, Ph.D. Functional MRI laboratory University of Michigan 1 OVERVIEW Quick review of ASL The niche for ASL Examples of practical applications in
More informationNBQX, An AMPA/Kainate Glutamate Receptor Antagonist, Alleviates Joint Disease In Models Of Inflammatory- And Osteo- Arthritis.
NBQX, An AMPA/Kainate Glutamate Receptor Antagonist, Alleviates Joint Disease In Models Of Inflammatory- And Osteo- Arthritis. Cleo S. Bonnet, PhD 1, Anwen S. Williams, PhD 1, Sophie J. Gilbert, PhD 1,
More information#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by
#CHAIR2016 September 15 17, 2016 The Biltmore Hotel Miami, FL Sponsored by Bending the Illness Curve: A New Treatment Model for Early Stage Psychoses Jeffrey A. Lieberman, M.D. Columbia University College
More informationAdverse events of common psychiatric medications: an umbrella review
Adverse events of common psychiatric medications: an umbrella review Katrina Bartellas, 1 Thomas Bajorek 1 Sarah Stockton, 1 Stefan Leucht, 2 Andrea Cipriani, 1 Seena Fazel 1 1 Department of Psychiatry,
More informationPharmacology, Biochemistry and Behavior
Pharmacology, Biochemistry and Behavior 91 (2009) 610 620 Contents lists available at ScienceDirect Pharmacology, Biochemistry and Behavior journal homepage: www.elsevier.com/locate/pharmbiochembeh Mutant
More informationLong-term associations between use of antipsychotic medication and brain structural changes in schizophrenia
Long-term associations between use of antipsychotic medication and brain structural changes in schizophrenia a systematic review and a meta-analysis Jouko Miettunen Center for Life Course Epidemiology
More informationEffectiveness of paliperidone long-acting injection in clinical practice.
Ther Adv Psychopharmacol (2018) 1 7 doi: 10.1177/ 2045125317753332 Effectiveness of paliperidone long-acting injection in clinical practice. Paul Nicholas Deslandes 1,2, Elan Haf Ward 3, Kathryn Norris
More informationDisease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland
Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the
More informationThe genetics of complex traits Amazing progress (much by ppl in this room)
The genetics of complex traits Amazing progress (much by ppl in this room) Nick Martin Queensland Institute of Medical Research Brisbane Boulder workshop March 11, 2016 Genetic Epidemiology: Stages of
More informationBiomarkers in Schizophrenia
Biomarkers in Schizophrenia David A. Lewis, MD Translational Neuroscience Program Department of Psychiatry NIMH Conte Center for the Neuroscience of Mental Disorders University of Pittsburgh Disease Process
More informationAN INTRODUCTION TO EPIGENETICS DR CHLOE WONG
AN INTRODUCTION TO EPIGENETICS DR CHLOE WONG MRC SGDP CENTRE, INSTITUTE OF PSYCHIATRY KING S COLLEGE LONDON Oct 2015 Lecture Overview WHY WHAT EPIGENETICS IN PSYCHIARTY Technology-driven genomics research
More informationIndividualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool
Copyright John Donoghue 2015 Individualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool Copyright John Donoghue 2015 QUESTIONS Why do outcomes in schizophrenia remain
More informationSupplementary Information Titles Journal: Nature Medicine
Supplementary Information Titles Journal: Nature Medicine Article Title: Corresponding Author: Supplementary Item & Number Supplementary Fig.1 Fig.2 Fig.3 Fig.4 Fig.5 Fig.6 Fig.7 Fig.8 Fig.9 Fig. Fig.11
More informationHost Genomics of HIV-1
4 th International Workshop on HIV & Aging Host Genomics of HIV-1 Paul McLaren École Polytechnique Fédérale de Lausanne - EPFL Lausanne, Switzerland paul.mclaren@epfl.ch Complex trait genetics Phenotypic
More information